Information on Poxel's capital and voting rights

Poxel has announced details of its share capital as of June 30, 2025. The total number of shares comprising the capital amounts to 53,758,167. This same quantity represents the total number of gross voting rights. Regarding exercisable voting rights, there are 53,718,064, taking into account shares deprived of voting rights. This information is made public in accordance with Articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulations of the Financial Markets Authority.

Full details are available on Poxel's website, under the regulated information section. The company is listed on Euronext Paris and specializes in developing treatments for metabolic diseases.